Our Movement Disorders fellowship is one or two years in length. Our long established Fellowship program, initiated in 1990s, provides comprehensive Clinical Movement Disorders subspecialty training. (There is no ACGME accreditation for a movement disorders subspecialty at this time.)

Applications accepted via SF Match (https://www.sfmatch.org/) Movement Disorders.

Interviews in spring/summer in calendar year prior to start. Rank list deadline for SF Match is (typically) in September.  Movement Disorders Fellowship begins here in July of the following calendar year.

 

Eligible candidates

  • Will have completed Neurology Residency program in good standing prior to start date.
  • Clinical letters of recommendations from an accredited Neurology Residency program.
  • Augusta University requires a J-1 Visa.

Subspecialties

Clinical and research training by three attending Movement Disorder specialists at the Medical College of Georgia.

  • A wide catchment of Parkinson’s Disease evaluations via our Parkinson’s Center of Excellence. MCG was the first Parkinson’s Foundation Center of Excellence in Georgia or South Carolina.
  • Atypical Parkinsonism syndromes
  • Disabling Essential Tremor
  • Dystonia syndromes
  • Huntington’s Disease
  • Ataxia syndromes
  • Heterogeneous additional movement disorders

Additional Memory disorders exposure is available to interested Fellows, from Movement and Memory Director and specialist Dr. John Morgan, via the “Georgia Memory Net” dementia evaluation initiative clinic at Medical College of Georgia.

photo of John Morgan, MD, PhD

John Morgan, MD, PhD

  • Director, Movement Disorders Program
  • Movement Disorders Specialist

706-721-2798

 

Advanced movement disorders therapy training includes 

  • Application of clinical genetics and basic genetic counseling.
  • Deep Brain Stimulation (DBS) clinical evaluations, participation in monthly DBS interdisciplinary case conferences.
  • DBS stereotactic surgical planning.
  • Movement Neurologist led DBS intraoperative electrophysiology.
  • Botulinum toxin application for movement disorders, additional applications, procedural competence.
  • Additional advanced Parkinson’s disease therapies (e.g. intestinal gel infusion programming).
  • Exposure to ongoing movement disorders clinical trials for hands on exposures to the next wave of therapies and research. 
photo of Julie A. Kurek, MD

Julie A. Kurek, MD

  • Medical Director of the MCG/AU Parkinson’s Foundation Center of Excellence
  • Movement Disorders Specialist

706-721-5988

photo of Colin McLeod, MD

Colin McLeod, MD

  • Director of the Movement Disorders Fellowship Program
  • Movement Disorders Specialist

706-721-1691

photo of Elizabeth Prince-Coleman PA-C

Elizabeth Prince-Coleman PA-C

  • Physician Assistant

Kathleen Kane PA-C

  • Physician Assistant